Please login to the form below

Not currently logged in
Email:
Password:

health technology assessment

This page shows the latest health technology assessment news and features for those working in and with pharma, biotech and healthcare.

NICE International relaunches, will offer advisory services

NICE International relaunches, will offer advisory services

This support will help those outside the UK develop similar systems which improve health and social care evidence-based decision making, and help to embed health technology assessment by allocating resources ... NICE has become one of the world’s most

Latest news

  • NICE’s long-serving chief exec Sir Andrew Dillon to step down NICE’s long-serving chief exec Sir Andrew Dillon to step down

    NICE quickly became the world’s  best-known and most prominent health technology assessment (HTA) body, and has set the standard for many other national institutes set up since then. ... NICE has made a significant contribution to improving outcomes

  • Who's calling the shots in European healthcare? Who's calling the shots in European healthcare?

    2019 has already been very eventful in terms of the debate about pharma’s future, including the question of how to proceed with plans for harmonisation of health technology assessment (HTA) ... The EMA is there to protect and promote public health, not

  • Europe urged to adapt faster to gene therapy challenges Europe urged to adapt faster to gene therapy challenges

    Resistance to high prices, even with novel payment models. Europe’s leading nations should commit to a rapid overhaul of health technology assessment (HTA) and bold initiatives such as new ... Better-adapted health technology assessment (HTA) methods,

  • European elections: Eurosceptics and Greens rise, but big parties hold on European elections: Eurosceptics and Greens rise, but big parties hold on

    An even clearer threat to public health and to pharma has been the anti-vax movement, which has gained a voice among Italy’s populist eruptions in particular. ... Probably the biggest outstanding issue is the future of plans to introduce EU-wide health

  • Akcea steals march on Alnylam with NICE approval Akcea steals march on Alnylam with NICE approval

    We hope that other health technology assessment and reimbursement agencies across Europe will take NICE’s lead in making inotersen available as a treatment option for patients with this disease.".

More from news
Approximately 2 fully matching, plus 153 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 47 partially matching documents found.

Latest appointments

  • VCLS appoints Carole Jones to senior market access role VCLS appoints Carole Jones to senior market access role

    her focus on expanding the company’s market access capabilities, spanning payer strategy, health economics and outcomes research (HEOR), health technology assessment (HTA) and communications support. ... The combination of world class regulatory and

  • EFPIA's Richard Torbett to move to the ABPI EFPIA's Richard Torbett to move to the ABPI

    with the Department of Health around the PPRS.”. ... At the ABPI Torbett will focus on pricing, the Pharmaceutical Price Regulation Scheme (PPRS), health technology assessments (HTA) and value assessment, as well as market access in the UK.

  • ABPI appoints value and access manager ABPI appoints value and access manager

    Rowland will work on a range of projects to improve patient access to innovative medicines, in line with the ABPI's strategic objectives around health technology assessment and market access. ... I am delighted to join the ABPI at this time of great

  • Former NICE chair joins board of biotech Former NICE chair joins board of biotech

    I no longer have anything to do with [NICE],” he told the FT, clarifying his future influence on the health technology assessment (HTA) body. ... His expertise in the cost-effectiveness of new pharmaceuticals and other issues in health economics will

  • Access Partnership expands its senior team Access Partnership expands its senior team

    His international experience extends to product development and commercialisation, health economics, health outcomes research, health technology assessment, market access and pricing strategies.

More from appointments
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 3 fully matching, plus 8 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Healthcircle

We're Healthcircle – an award-winning healthcare advertising and creative communications agency, offering a holistic approach to brand health. With a...

Latest intelligence

Women in science
The role of women in science and technology
Why the lack of female leaders in pharma and life sciences is a problem that still needs to be fixed...
Maria Dahl
China’s homecoming heroes fuel a biotech boom with rapid CAR-T advances
China secures a place at the forefront of innovative medicine...
Virtual Research Grants Submission and Approval Program
Impetus Digital summarizes how a client established an independent grant review committee and a virtual grant submission and approval program, without having to travel and meet in person....

Infographics